Jim Xiang

6.7k citations

186 papers · 5.4k indexed · h-index 41

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers

Papers in

Immunology 132
- Immunotherapy and Immune Responses 113
- T-cell and B-cell Immunology 62
- Immune Cell Function and Interaction 60
Oncology 68
- CAR-T cell therapy research 47

Co-authors: Terence Moyana Yufeng Xie Siguo Hao Khawaja Ashfaque Ahmed Zhaoying Fu Jinying YuanHui HuangJohn Gordon
Journals: Cancer Biotherapy and Radiopharmaceuticals (24 papers)The Journal of Immunology (13 papers)Cellular and Molecular Immunology (11 papers)Biochemical and Biophysical Research Communications (10 papers)International Journal of Molecular Sciences (9 papers)
Partner nations: Canada China United States

In The Last Decade

Jim Xiang

183 papers receiving 5.3k citations

Peers

Countries citing papers authored by Jim Xiang

Since Specialization

Citations

This map shows the geographic impact of Jim Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Xiang more than expected).

Fields of papers citing papers by Jim Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Xiang. The network helps show where Jim Xiang may publish in the future.

Co-authors

The 25 scholars most cited alongside Jim Xiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jim Xiang Line = papers co-authored together Jim Xiang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Heterologous human/rat HER2-specific exosome-targeted T cell vaccine stimulates potent humoral and CTL responses leading to enhanced circumvention of HER2 tolerance in double transgenic HLA-A2/HER2 mice Vaccine ·Yufeng Xie, Jie Wu, Aizhang Xu, Shahid Ahmeqd, Amer Sami, Rajni Chibbar, Andrew Freywald, Changyu Zheng, Jim Xiang	2018	25
2	Simulated microgravity inhibits cell focal adhesions leading to reduced melanoma cell proliferation and metastasis via FAK/RhoA-regulated mTORC1 and AMPK pathways Scientific Reports ·Xin Tan, Aizhang Xu, Tuo Zhao, Qin Zhao, Jun Zhang, Cuihong Fan, Yulin Deng, Andrew Freywald, Harald Genth, Jim Xiang	2018	67
3	Innate and Adoptive Immune Cells Contribute to Natural Resistance to Systemic Metastasis of B16 Melanoma Cancer Biotherapy and Radiopharmaceuticals ·Channakeshava Sokke Umeshappa, Yehan Zhu, Kalpana K. Bhanumathy, Maxwell Omabe, Rajni Chibbar, Jim Xiang	2015	5
4	Mechanisms of cellular communication through intercellular protein transfer Journal of Cellular and Molecular Medicine ·Khawaja Ashfaque Ahmed, Jim Xiang	2010	115
5	Tumor Apoptotic Bodies Inhibit CTL Responses and Antitumor Immunity via Membrane-Bound Transforming Growth Factor-β1 Inducing CD8+ T-Cell Anergy and CD4+ Tr1 Cell Responses Cancer Research ·Yufeng Xie, Ou Bai, Jinying Yuan, Rajni Chibbar, Karen Slattery, Yangdou Wei, Yulin Deng, Jim Xiang	2009	53
6	Membrane‐bound HSP70‐engineered myeloma cell‐derived exosomes stimulate more efficient CD8⁺ CTL‐ and NK‐mediated antitumour immunity than exosomes released from heat‐shocked tumour cells expressing cytoplasmic HSP70 Journal of Cellular and Molecular Medicine ·Yufeng Xie, Ou Bai, Haifeng Zhang, Jinying Yuan, Sam Zong, Rajni Chibbar, Karen Slattery, Mabood Qureshi, Yangdou Wei, Yulin Deng, Jim Xiang	2009	147
7	T cell precursor frequency differentially affects CTL responses under different immune conditions Biochemical and Biophysical Research Communications ·Zhenmin Ye, Khawaja Ashfaque Ahmed, Junqiong Huang, Yufeng Xie, Manjunatha Ankathatti Munegowda, Jim Xiang	2008	5
8	Defect of CD8+ Memory T Cells Developed in Absence of IL-12 Priming for Secondary Expansion Cellular and Molecular Immunology ·Zhenmin Ye, Shulin Xu, Terence Moyana, Jicheng Yang, Jim Xiang	2008	10
9	Adenovirus-mediated ING4 expression suppresses lung carcinoma cell growth via induction of cell cycle alteration and apoptosis and inhibition of tumor invasion and angiogenesis Cancer Letters ·Yufeng Xie, Haifeng Zhang, Weihua Sheng, Jim Xiang, Zhenmin Ye, Jicheng Yang	2008	57
10	Review: Cancer Immunotherapy by Exosome-Based Vaccines Cancer Biotherapy and Radiopharmaceuticals ·Siguo Hao, Terence Moyana, Jim Xiang	2007	56
11	Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors Cell Research ·Dajing Xia, Terence Moyana, Jim Xiang	2006	26
12	Oncolytic Adenovirus-Mediated E1A Gene Therapy Induces Tumor-Cell Apoptosis and Reduces Tumor Angiogenesis Leading to Inhibition of Hepatocellular Carcinoma Growth in Animal Model Cancer Biotherapy and Radiopharmaceuticals ·Zhenmin Ye, Xiaohua Wang, Siguo Hao, Jiang Zhong, Jim Xiang, Jicheng Yang	2006	16
13	Tumor-Infiltrating Dendritic Cell Subsets of Progressive or Regressive Tumors Induce Suppressive or Protective Immune Responses Cancer Research ·Yongqing Liu, Xuguang Bi, Shulin Xu, Jim Xiang	2005	22
14	Significant Tumor Regression Induced by Microencapsulation of Recombinant Tumor Cells Secreting Fusion Protein Cancer Biotherapy and Radiopharmaceuticals ·Meiqing Shi, Siguo Hao, Mabood Quereshi, Xulin Guo, Changyu Zheng, Jim Xiang	2005	7
15	Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor Cancer Gene Therapy ·Zhuang Chen, Hui Huang, Tim Chang, Svein A. Carlsen, Anurag Saxena, Robert A. Marr, Zhou Xing, Jim Xiang	2002	29
16	Regression of engineered myeloma cells secreting interferon-γ-inducing factor is mediated by both CD4+/CD8+ T and natural killer cells Leukemia Research ·Jim Xiang, Zhuang Chen, Hui Huang, Terence Moyana	2001	15
17	Neutrophils and B Cells Express XCR1 Receptor and Chemotactically Respond to Lymphotactin Biochemical and Biophysical Research Communications ·Hui Huang, Fang Li, Chantelle Cairns, John Gordon, Jim Xiang	2001	55
18	Regression of Engineered Tumor Cells Secreting Cytokines Is Related to a Shift in Host Cytokine Profile from Type 2 to Type 1 Journal of Interferon & Cytokine Research ·Jim Xiang, Terence Moyana	2000	30
19	A genetically engineered single-chain FVTNF molecule possesses the anti-tumor immunoreactivity of FV as well as the cytotoxic activity of tumor necrosis factor Molecular Immunology ·J. C. Yang, Terence Moyana, Jim Xiang	1995	21
20	Development of the Early Mucosal Lesions in Experimental Inflammatory Bowel Disease—Implications for Pathogenesis Experimental and Molecular Pathology ·Terence Moyana, Jim Xiang, Yimin Qi, Jawahar Kalra	1994	3

About Jim Xiang

Jim Xiang is a scholar working on Immunology, Oncology, Biotechnology, Aging and Radiology, Nuclear Medicine and Imaging, having authored 186 papers that have together received 5.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (113 papers), T-cell and B-cell Immunology (62 papers), Immune Cell Function and Interaction (60 papers), CAR-T cell therapy research (47 papers), Monoclonal and Polyclonal Antibodies Research (32 papers), Virus-based gene therapy research (28 papers), Cancer Research and Treatments (17 papers) and RNA Interference and Gene Delivery (17 papers). The work is most often cited by research in Immunology (2.9k citations), Oncology (1.5k citations), Cancer Research (821 citations), Molecular Biology (2.7k citations) and Aging (52 citations). Jim Xiang has collaborated with scholars based in Canada, China and United States. Frequent co-authors include Terence Moyana, Yufeng Xie, Siguo Hao, Khawaja Ashfaque Ahmed, Zhaoying Fu, Jinying Yuan, Hui Huang, John Gordon, Rajni Chibbar and Ou Bai. Their work appears in journals such as Cancer Biotherapy and Radiopharmaceuticals, The Journal of Immunology, Cellular and Molecular Immunology, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact